Cytosorbents is a therapeutic device company that uses blood purification to modulate the immune system and fight multi-organ failure in life-threatening illnesses. In 2011, the company’s CytoSorb® was approved in the European Union as a cytokine filter to be used in clinical situations where cytokines are elevated, and can be used in many different illnesses seen in the intensive care unit, including sepsis, trauma, burn injury, acute respiratory distress syndrome and pancreatitis. For more information visit the company’s Web site at www.cytosorbents.com.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research, sales, and trading services. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.

Let us hear your thoughts below: